Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 6
2006 9
2007 20
2008 9
2009 15
2010 11
2011 13
2012 15
2013 8
2014 7
2015 6
2016 5
2017 4
2018 1
2019 3
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

115 results
Results by year
Filters applied: . Clear all
Page 1
Incorporating Parp-inhibitors in Primary and Recurrent Ovarian Cancer: A Meta-analysis of 12 phase II/III randomized controlled trials.
Ruscito I, Bellati F, Ray-Coquard I, Mirza MR, du Bois A, Gasparri ML, Costanzi F, De Marco MP, Nuti M, Caserta D, Pignata S, Dorigo O, Sehouli J, Braicu EI. Ruscito I, et al. Among authors: bellati f. Cancer Treat Rev. 2020 Jul;87:102040. doi: 10.1016/j.ctrv.2020.102040. Epub 2020 May 26. Cancer Treat Rev. 2020. PMID: 32485510
Vaginal cancer.
Di Donato V, Bellati F, Fischetti M, Plotti F, Perniola G, Panici PB. Di Donato V, et al. Among authors: bellati f. Crit Rev Oncol Hematol. 2012 Mar;81(3):286-95. doi: 10.1016/j.critrevonc.2011.04.004. Epub 2011 May 14. Crit Rev Oncol Hematol. 2012. PMID: 21571543 Review.
The role of vaginal brachytherapy in stage I endometrial serous cancer: a systematic review.
Lancellotta V, De Felice F, Vicenzi L, Antonacci A, Cerboneschi V, Costantini S, di Cristino D, Tagliaferri L, Cerrotta A, Vavassori A, Gribaudo S, Colombo A, LucĂ  F, Barbara R, Mangoni M, Marampon F, Musio D, Bellati F, Torcia F, Tombolini V, Osti MF, De Sanctis V. Lancellotta V, et al. Among authors: bellati f. J Contemp Brachytherapy. 2020 Feb;12(1):61-66. doi: 10.5114/jcb.2020.92698. Epub 2020 Feb 28. J Contemp Brachytherapy. 2020. PMID: 32190072 Free PMC article. Review.
Monoclonal antibodies therapies for ovarian cancer.
Leone Roberti Maggiore U, Bellati F, Ruscito I, Gasparri ML, Alessandri F, Venturini PL, Ferrero S. Leone Roberti Maggiore U, et al. Among authors: bellati f. Expert Opin Biol Ther. 2013 May;13(5):739-64. doi: 10.1517/14712598.2013.767328. Epub 2013 Feb 4. Expert Opin Biol Ther. 2013. PMID: 23373587 Review.
Olaparib, PARP1 inhibitor in ovarian cancer.
Marchetti C, Imperiale L, Gasparri ML, Palaia I, Pignata S, Boni T, Bellati F, Benedetti Panici P. Marchetti C, et al. Among authors: bellati f. Expert Opin Investig Drugs. 2012 Oct;21(10):1575-84. doi: 10.1517/13543784.2012.707189. Epub 2012 Jul 13. Expert Opin Investig Drugs. 2012. PMID: 22788971 Review.
Tertiary cytoreduction for recurrent endometrial cancer.
Bellati F, Papadia A, Gasparri ML, Scanagatta P, Carriero F, Beneditti Panici P, Raspagliesi F. Bellati F, et al. Eur J Gynaecol Oncol. 2017;38(1):132-134. Eur J Gynaecol Oncol. 2017. PMID: 29767882
Role of chemotherapy in the management of vulvar carcinoma.
Tomao F, Di Tucci C, Marchetti C, Perniola G, Bellati F, Panici PB. Tomao F, et al. Among authors: bellati f. Crit Rev Oncol Hematol. 2012 Apr;82(1):25-39. doi: 10.1016/j.critrevonc.2011.04.008. Epub 2011 May 20. Crit Rev Oncol Hematol. 2012. PMID: 21601474 Review.
115 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page